Einträge von Kahl, Christoph auf dem Publikationsserver

Vogt, Jeannette , Beyer, Franziska, Sistermanns, Jochen, Kuon, Jonas, Kahl, Christoph, Alt-Epping, Bernd, Stevens, Susanne, Ahlborn, Miriam, George, Christian, Heider, Andrea, Tienken, Maria, Loquai, Carmen, Stahlhut, Kerstin, Ruellan, Anne, Kubin, Thomas, Dietz, Andreas, Oechsle, Karin, Mehnert-Theuerkauf, Anja , Oorschot, Birgitt, Thomas, Michael, Ortmann, Olaf, Engel, Christoph und Lordick, Florian (2021) Symptom Burden and Palliative Care Needs of Patients with Incurable Cancer at Diagnosis and During the Disease Course. The Oncologist 26 (6), e1058-e1065.

Vogel, Arndt, Kasper, Stefan , Bitzer, Michael, Block, Andreas, Sinn, Marianne, Schulze-Bergkamen, Henning, Moehler, Markus, Pfarr, Nicole, Endris, Volker, Goeppert, Benjamin , Merx, Kirsten, Schnoy, Elisabeth, Siveke, Jens T., Michl, Patrick, Waldschmidt, Dirk, Kuhlmann, Jan, Geissler, Michael, Kahl, Christoph, Evenkamp, Ralph, Schmidt, Torben, Kuhlmann, Alexander, Weichert, Wilko und Kubicka, Stefan (2018) PICCA study: panitumumab in combination with cisplatin/gemcitabine chemotherapy in KRAS wild-type patients with biliary cancer—a randomised biomarker-driven clinical phase II AIO study. European Journal of Cancer 92, S. 11-19. Volltext nicht vorhanden.

Vogel, Arndt, Kasper, Stefan, Weichert, Wilko, Bitzer, Michael, Block, Andreas, Riess, Hanno, Schulze-Bergkamen, Henning, Moehler, Markus H., Merx, Kirsten Elisabeth, Endris, Volker, Schnoy, Elisabeth, Siveke, Jens T., Michl, Patrick, Waldschmidt, Dirk, Kuhlmann, Jan, Geissler, Michael, Kahl, Christoph und Kubicka, Stefan (2015) Panitumumab in combination with gemcitabine/cisplatin (GemCis) for patients with advanced kRAS WT biliary tract cancer: A randomized phase II trial of the Arbeitsgemeinschaft Internistische Onkologie (AIO). Journal of Clinical Oncology 33 (15_sup), S. 4082. Volltext nicht vorhanden.